BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 37781517)

  • 1. The emerging roles of metabolism in the crosstalk between breast cancer cells and tumor-associated macrophages.
    Liang Y; He J; Chen X; Yin L; Yuan Q; Zeng Q; Zu X; Shen Y
    Int J Biol Sci; 2023; 19(15):4915-4930. PubMed ID: 37781517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic reprogramming in the immunosuppression of tumor-associated macrophages.
    Wang Y; Wang D; Yang L; Zhang Y
    Chin Med J (Engl); 2022 Oct; 135(20):2405-2416. PubMed ID: 36385099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated macrophages: new insights on their metabolic regulation and their influence in cancer immunotherapy.
    Xiao L; Wang Q; Peng H
    Front Immunol; 2023; 14():1157291. PubMed ID: 37426676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic regulatory crosstalk between tumor microenvironment and tumor-associated macrophages.
    Chen D; Zhang X; Li Z; Zhu B
    Theranostics; 2021; 11(3):1016-1030. PubMed ID: 33391518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel insight into cancer therapy: Lipid metabolism in tumor-associated macrophages.
    Ren Y; Wang M; Yuan H; Wang Z; Yu L
    Int Immunopharmacol; 2024 Jun; 135():112319. PubMed ID: 38801810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment.
    Li L; Tian Y
    Biomed Pharmacother; 2023 May; 161():114504. PubMed ID: 37002579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid Metabolic Regulatory Crosstalk Between Cancer Cells and Tumor-Associated Macrophages.
    Liu S; Shen YY; Yin LY; Liu J; Zu X
    DNA Cell Biol; 2023 Aug; 42(8):445-455. PubMed ID: 37535386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy.
    Li L; Ma SR; Yu ZL
    Cell Oncol (Dordr); 2024 Apr; 47(2):415-428. PubMed ID: 37776422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunometabolic attributes and mitochondria-associated signaling of Tumor-Associated Macrophages in tumor microenvironment modulate cancer progression.
    Dubey S; Ghosh S; Goswami D; Ghatak D; De R
    Biochem Pharmacol; 2023 Feb; 208():115369. PubMed ID: 36481347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic crosstalk in the breast cancer microenvironment.
    Dias AS; Almeida CR; Helguero LA; Duarte IF
    Eur J Cancer; 2019 Nov; 121():154-171. PubMed ID: 31581056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles of non-coding RNAs in the metabolic reprogramming of tumor-associated macrophages.
    Li J; Lu Z; Zhang Y; Xia L; Su Z
    Immunol Lett; 2021 Apr; 232():27-34. PubMed ID: 33577913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophages and Metabolism in the Tumor Microenvironment.
    Vitale I; Manic G; Coussens LM; Kroemer G; Galluzzi L
    Cell Metab; 2019 Jul; 30(1):36-50. PubMed ID: 31269428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unveiling the veil of lactate in tumor-associated macrophages: a successful strategy for immunometabolic therapy.
    Tao H; Zhong X; Zeng A; Song L
    Front Immunol; 2023; 14():1208870. PubMed ID: 37564659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy.
    Khan SU; Khan MU; Azhar Ud Din M; Khan IM; Khan MI; Bungau S; Hassan SSU
    Front Immunol; 2023; 14():1166487. PubMed ID: 37138860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Metabolic Features of Tumor-Associated Macrophages: Opportunities for Immunotherapy?
    Mojsilovic SS; Mojsilovic S; Villar VH; Santibanez JF
    Anal Cell Pathol (Amst); 2021; 2021():5523055. PubMed ID: 34476174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting tumor-associated macrophages for cancer immunotherapy.
    Cao X; Lai SWT; Chen S; Wang S; Feng M
    Int Rev Cell Mol Biol; 2022; 368():61-108. PubMed ID: 35636930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-Associated Macrophages: Critical Players in Drug Resistance of Breast Cancer.
    Xiao M; He J; Yin L; Chen X; Zu X; Shen Y
    Front Immunol; 2021; 12():799428. PubMed ID: 34992609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
    Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
    Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated macrophages: Potential target of natural compounds for management of breast cancer.
    Malla R; Padmaraju V; Kundrapu DB
    Life Sci; 2022 Jul; 301():120572. PubMed ID: 35489567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of chemokines in the crosstalk between tumor and tumor-associated macrophages.
    Qin R; Ren W; Ya G; Wang B; He J; Ren S; Jiang L; Zhao S
    Clin Exp Med; 2023 Sep; 23(5):1359-1373. PubMed ID: 36173487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.